|
Status |
Public on Dec 31, 2016 |
Title |
Exosomal miRNA in liver disease |
Organism |
Homo sapiens |
Experiment type |
Non-coding RNA profiling by array
|
Summary |
Aiming to develop novel biomarker for cancer prediction after successful treatment of interferon therapy SVR-HCC is HCC appearance after IFN treatment. Each sample was collected 3 times; before IFN treatment, after IFN treatment, and appearance of HCC in SVR-HCC group. HCV-CHC is not HCC appearance after interferon treatment. Each sample was collected three times, before IFN treatment, after IFN treatment, and observation period after IFN treatment. For example, the sample which is SVR-HCC002-1 is the patient who suffered from HCC after IFN treatment, was collected before IFN treatment. SVR-HCC001-3 is missing.
|
|
|
Overall design |
42 HCC related patients
|
|
|
Contributor(s) |
Murakami Y, Itami S |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Aug 16, 2016 |
Last update date |
Jan 24, 2019 |
Contact name |
Satoshi Kondo |
Organization name |
Toray Industries,Inc.
|
Street address |
10-1 tebiro 6-chome
|
City |
Kamakura |
State/province |
Kanagawa |
ZIP/Postal code |
248-8555 |
Country |
Japan |
|
|
Platforms (1) |
|
Samples (125)
|
|
This SubSeries is part of SuperSeries: |
GSE85680 |
Exosomal or serum miRNA in liver disease |
|
Relations |
BioProject |
PRJNA339200 |